Dice Molecules Holdings LLC

Company Profile

Dice Molecules Holdings LLC had its IPO on 2021-09-15 under the ticker symbol DICE.

The company operates in the Healthcare sector and Biotechnology industry. Dice Molecules Holdings LLC has a staff strength of 81 employees.

Stock update

Shares of Dice Molecules Holdings LLC opened at $47.55 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $47.55 - $47.55, and closed at $47.55.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Dice Molecules Holdings LLC have increased by 0%.

Dice Molecules Holdings LLC's Key Ratios

Dice Molecules Holdings LLC has a market cap of $1.47 billion, indicating a price to book ratio of 5.9124 and a price to sales ratio of 699.0015.

In the last 12-months Dice Molecules Holdings LLC’s revenue was $0 with a gross profit of $-56075000 and an EBITDA of $-100020000. The EBITDA ratio measures Dice Molecules Holdings LLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Dice Molecules Holdings LLC’s operating margin was 0% while its return on assets stood at -14.02% with a return of equity of -21.6%.

In Q1, Dice Molecules Holdings LLC’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Dice Molecules Holdings LLC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.06 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dice Molecules Holdings LLC’s profitability.

Dice Molecules Holdings LLC stock is trading at a EV to sales ratio of 438.0417 and a EV to EBITDA ratio of -17.298. Its price to sales ratio in the trailing 12-months stood at 699.0015.

Dice Molecules Holdings LLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$575.60 million

Total Liabilities

$17.24 million

Operating Cash Flow

$-337655000.00

Capital Expenditure

$202000

Dividend Payout Ratio

0%

Dice Molecules Holdings LLC ended 2024 with $575.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $575.60 million while shareholder equity stood at $-213240000.00.

Dice Molecules Holdings LLC ended 2024 with $0 in deferred long-term liabilities, $17.24 million in other current liabilities, 5000.00 in common stock, $-213240000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $101.59 million and cash and short-term investments were $554.55 million. The company’s total short-term debt was $1,479,000 while long-term debt stood at $0.

Dice Molecules Holdings LLC’s total current assets stands at $559.35 million while long-term investments were $0 and short-term investments were $452.95 million. Its net receivables were $0 compared to accounts payable of $4.12 million and inventory worth $0.

In 2024, Dice Molecules Holdings LLC's operating cash flow was $-337655000.00 while its capital expenditure stood at $202000.

Comparatively, Dice Molecules Holdings LLC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$47.55

52-Week High

$45.99

52-Week Low

$12.635

Analyst Target Price

$63

Dice Molecules Holdings LLC stock is currently trading at $47.55 per share. It touched a 52-week high of $45.99 and a 52-week low of $45.99. Analysts tracking the stock have a 12-month average target price of $63.

Its 50-day moving average was $45.12 and 200-day moving average was $34.83 The short ratio stood at 16.78 indicating a short percent outstanding of 0%.

Around 332.3% of the company’s stock are held by insiders while 10426.5% are held by institutions.